4D Molecular Therapeutics Company

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Total Funding: 174999995
Headquarters: Emeryville, California, United States
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Last Funding Type: Series C
Investor Type: IPO
Last Funding Date: 2020
Investors Number: 20
Founded Date: 2013
Industry: Biotechnology, Genetics